Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VICL (Vical Labs) -- Ignore unavailable to you. Want to Upgrade?

To: Scott H. Davis who wrote (1177)	12/28/1999 10:10:00 PM
From: William Strop	Respond to of 1972

Scott, I talked to Alan Engbring when we were at around 22, before the drop to 18 & now the subsequent advance. His thoughts were that possibly everyone who wanted to sell did so in July/99 with the 4 million share day. This left the long term dregs like us. Also that there was certainly someone(s) accumulating (as can be seen at the end of most trading days). They may have to file a 'xx-y' if they have accumulated enough. What I think, fwiw, is that over the years Vical has made steady, consistent, usually slow progress for Vical the Company while Vical the stock traded from 7-16. The 'progress' that was being made was never reflected in the stock price. Just maybe that reflection is starting to happen. And if I jinx the rally by saying that -- sorry. But I have always believed since 3/94 (and still believe) that they have great promise and if they continue to 'deliver' on their many pipelines the stock price will certainly appreciate. Glad to hear you got a double... Bill

To: Scott H. Davis who wrote (1177)	12/28/1999 10:27:00 PM
From: William Strop	Read Replies (2) \| Respond to of 1972

Scott, Here is a post from 20 months ago mentioning patience... * Start * To: Scott H. Davis who wrote (686) From: William Strop Sunday, May 3, 1998 10:38 PM ET Scott, I agree that Vical is still a good investment. I've made it through three years & hopefully the next three will show the value of patience. I looked back over my 2 investment notebooks on Vical this rainy afternoon to remind myself why I bought it. The old articles dating back to 1993 all tout the value of the naked DNA vaccines. I don't think that that has ever changed. It is just the amazing span of time that is necessary to go from discovery to distribution that is worthy of being reminded of. So doing that, I was duly reminded and will wait for at least another 3-5 years as long as we have continual clinical success. Bill * End * Do you think this move is rooted by past performance or by anticipated events? b